Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose versus 5-day cefazolin prophylaxis in revision hip and knee arthroplasty
NL-OMON48292Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- Nov 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin in periprosthetic joint infection (PJI) (2 arms), sponsored by Sint Maartenskliniek. Started Nov 2019; status: completed.
02
Drugs
cefazolin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NL-OMON48292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48292.